Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J

This article was originally published in The Tan Sheet

Executive Summary

William Weldon named vice chairman, overseeing Pharmaceuticals Group, Consumer Pharmaceuticals & Nutritional Products Group, corporate office of science & technology and corporate business development. Group Chairman Robert Savage replaces Weldon as global Rx chairman. Worldwide Medical Devices & Diagnostics Group Chairman James Lenehan also is elevated to vice chairman. Both vice chairmen will report jointly to CEO Ralph Larsen and Senior Vice Chairman Robert Wilson. Management reshuffling may signal a succession race under Larsen. During a recent conference call the CEO discouraged speculation he is considering retiring but acknowledged importance of a clear succession plan
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS092198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel